CatalystPit

LPCNLipocine Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $2.20 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$18.14M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Higuchi John W. (Director) · BUY
  • 2026-09-30 · Higuchi John W. (Director) · BUY
  • 2026-04-07 · Higuchi John W. (Director) · BUY
  • 2026-04-06 · Patel Mahesh V. (Chief Executive Officer) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders38
Shares held3,291,621
Value$9.56M
Percent of shares outstanding39.93%
As of quarter end2026-06-30
RECENT NEWS
  • Lipocine receives Health Canada approval for TLANDO testosterone therapy
  • Lipocine director John Higuchi buys $55,042 in company stock
  • Lipocine director John Higuchi buys $27,131 in company stock
  • Lipocine initiates BLOOM Phase 3 study of LPCN 1154 for postpartum depression
  • Lipocine Inc. · 8-K (8.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Lipocine Inc. (LPCN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit